Cafepharma Today

April 19 2024 - Roche wins FDA OK for targeted drug in early lung cancer
Roche wins FDA OK for targeted drug in early lung cancer
How Vir found the one: CEO Marianne De Backer
Ozempic's latest reported side effect: pregnancy
FDA mandates label updates on CAR-T cancer therapies
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus
Motley Fool
Monday, August 8, 2011 - 9:18am
tags:
Dendreon, biotech, Provenge, prostate cancer
Cardiome Reports Second Quarter Results
Yahoo
Monday, August 8, 2011 - 9:17am
tags:
earnings, Cardiome
Teva Receives FDA Acceptance of Its New Drug Application for BDP Nasal HFA for the Treatment of Allergic Rhinitis
Yahoo
Monday, August 8, 2011 - 9:14am
tags:
Teva Pharmaceuticals, FDA, BDP Nasal HFA, allergic rhinitis
Valeant Pharma Beats, Ups View
Yahoo/Zacks.com
Monday, August 8, 2011 - 9:11am
tags:
earnings, Valeant Pharmaceuticals
What is Teva really worth?
Globes, Israel
Sunday, August 7, 2011 - 11:44am
tags:
Teva Pharmaceuticals
Dr Reddy's expects North American biz to drive growth this FY
Economic Times, India
Sunday, August 7, 2011 - 11:43am
tags:
Dr Reddy's
Generic drug industry slams special deal in patent reform bill
The Hill
Sunday, August 7, 2011 - 11:41am
tags:
generics
India's Aurobindo Pharma posts 1Q loss
MarketWatch
Saturday, August 6, 2011 - 1:56pm
tags:
Aurobindo, earnings
Qiagen Completes Second U.S. Submission For Companion Diagnostic To Guide Treatment Decisions In Colorectal Cancer
Biomed Reports
Saturday, August 6, 2011 - 1:53pm
tags:
Qiagen, KRAS assay, Erbitux, colorectal cancer
HHS-OIG Drops Potential Action against Forest CEO Howard Solomon
MarketWatch
Saturday, August 6, 2011 - 1:51pm
tags:
OIG, investigations, legal, Forest Labs
Enzon Inc. Reports Operating Results (10-Q)
GuruFocus
Saturday, August 6, 2011 - 1:29pm
tags:
Enzon, earnings
U.K. rejects MS drug over cost
Yahoo/Investor's Business Daily
Saturday, August 6, 2011 - 1:26pm
tags:
Novartis, multiple sclerosis, Gilenya
Novo Nordisk Revenues Up
Yahoo/Zacks
Saturday, August 6, 2011 - 1:25pm
tags:
Novo Nordisk, earnings
Lower Spending Boosts Par Pharma
Yahoo/Zacks
Saturday, August 6, 2011 - 1:24pm
tags:
Par Pharmaceutical
Big Pharma: M&A Spells Disaster for R&D
Seeking Alpha
Saturday, August 6, 2011 - 1:23pm
tags:
M&A, R&D
Momenta's earnings rise on market grab from Sanofi
bizjournals
Saturday, August 6, 2011 - 1:22pm
tags:
Momenta, Lovenox, Sanofi, generics
Surviving the Biotech Selloff (video)
The Street
Saturday, August 6, 2011 - 1:08pm
tags:
Sequenom's CEO Discusses Q2 2011 Results - Earnings Call Transcript
Seeking Alpha
Saturday, August 6, 2011 - 1:04pm
tags:
Sequenom, earnings
Halozyme Therapeutics Shares Popped: What You Need to Know
Motley Fool
Saturday, August 6, 2011 - 1:04pm
tags:
Halozyme, ViroPharma, Baxter International, rHuPH20
Loss at MannKind Wider than Expected
Yahoo/Zacks
Saturday, August 6, 2011 - 1:02pm
tags:
MannKind, earnings

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers
Drug Channels
The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels

Latest Jobs

Account Executive - Hospice
Buckner, MO, 64016
Agape Care Group
Account Executive - Hospice
Bates City, MO, 64011
Agape Care Group
Account Executive - Hospice
Kansas City, MO, 64171
Agape Care Group
Account Executive - Hospice
East Lynne, MO, 64743
Agape Care Group
Account Executive - Hospice
Mosby, MO, 64073
Agape Care Group
Account Executive - Hospice
Excelsior Springs, MO, 64024
Agape Care Group
Account Executive - Hospice
Warrensburg, MO, 64093
Agape Care Group
Account Executive - Hospice
Odessa, MO, 64076
Agape Care Group
Account Executive - Hospice
Henrietta, MO, 64036
Agape Care Group
Account Executive - Hospice
Knob Noster, MO, 65336
Agape Care Group
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information